Complete Filing Data
BioAtla, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $36.19 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BioAtla, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$59.6M | -$69.8M | -$123.5M | -$106.5M | -$95.4M | -$35.9M | -$29.9M |
| Research And Development Expense | $43.6M | $63.1M | $103.7M | $79.3M | $58.3M | $19.9M | $25.9M |
| Other Nonoperating Income Expense | -$302.0K | $4.2M | $6.2M | $1.7M | $1.0M | -$5.8M | -$1.6M |
| Operating Income Loss | -$59.3M | -$73.9M | -$129.7M | -$108.1M | -$96.4M | -$30.1M | -$28.3M |
| Operating Expenses | $61.3M | $84.9M | $129.7M | $108.1M | $96.7M | $30.5M | $33.5M |
| General And Administrative Expense | $17.7M | $21.8M | $26.0M | $28.8M | $38.4M | $10.6M | $7.5M |
| Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer | $2.0M | $11.0M | $0.00 | $0.00 | $250.0K | $429.0K | $5.2M |
| Interest Expense | $0.00 | $3.0K | $1.4M | $1.6M | |||
| Net Income Loss Available To Common Stockholders Basic | |||||||
| Interest Expense Related Party |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$15.8M | -$18.7M | -$15.3M | -$10.6M | -$21.1M | -$23.2M | -$33.3M | -$35.8M | -$27.5M | -$25.8M | -$28.9M | -$24.3M | -$22.9M | -$30.4M | -$18.7M | -$11.6M | -$6.2M | -$1.6M |
| Research And Development Expense | $9.5M | $13.7M | $12.4M | $16.4M | $16.2M | $18.9M | $28.4M | $31.0M | $21.7M | $19.8M | $20.7M | $16.9M | $16.6M | $14.9M | $10.4M | $4.9M | $2.9M | $1.7M |
| Other Nonoperating Income Expense | -$2.0M | -$64.0K | $2.3M | $684.0K | $900.0K | $1.2M | $1.7M | $1.4M | $1.5M | $400.0K | $149.0K | $92.0K | $765.0K | $79.0K | $96.0K | -$3.6M | -$1.7M | -$495.0K |
| Operating Income Loss | -$13.8M | -$18.6M | -$17.6M | -$11.3M | -$22.0M | -$24.5M | -$35.0M | -$37.2M | -$28.9M | -$26.2M | -$29.1M | -$24.3M | -$23.7M | -$30.5M | -$18.8M | -$8.0M | -$4.5M | -$1.1M |
| Operating Expenses | $13.8M | $18.6M | $17.6M | $22.3M | $22.0M | $24.5M | $35.0M | $37.2M | $28.9M | $26.2M | $29.1M | $24.3M | $23.7M | $30.7M | $18.8M | $8.2M | $4.7M | $1.2M |
| General And Administrative Expense | $4.3M | $5.0M | $5.3M | $5.9M | $5.8M | $5.6M | $6.6M | $6.2M | $7.2M | $6.3M | $8.3M | $7.4M | $7.1M | $15.9M | $8.4M | $3.3M | $1.8M | $463.0K |
| Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer | $0.00 | $11.0M | $0.00 | $0.00 | $250.0K | $0.00 | $150.0K | $190.0K | $89.0K | |||||||||
| Interest Expense | $0.00 | $1.0K | $2.0K | $86.0K | $754.0K | $547.0K | ||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$22.9M | -$30.4M | -$18.7M | -$11.6M | -$6.2M | -$1.6M | ||||||||||||
| Interest Expense Related Party | $0.00 | $0.00 | $0.00 | $9.0K | $79.0K | $59.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$36.2M | $14.3M | $70.7M | $180.3M | $210.8M | $210.0M | -$56.0M | -$28.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.1M | $49.0M | $111.5M | $215.5M | $245.0M | $238.6M | ||
| Cash And Cash Equivalents At Carrying Value | $7.1M | $49.0M | $111.5M | $215.5M | $245.0M | $238.6M | $3.7M | $10.9M |
| Taxes Related To Net Share Settlement Of Equity Awards | -$52.0K | -$46.0K | -$192.0K | -$534.0K | -$291.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$41.9M | -$62.4M | -$104.0M | -$29.5M | $6.4M | $234.9M | -$7.2M | |
| Retained Earnings Accumulated Deficit | -$545.6M | -$486.0M | -$416.3M | -$292.8M | -$186.3M | -$90.9M | ||
| Property Plant And Equipment Net | $120.0K | $678.0K | $1.6M | $2.7M | $3.7M | $4.1M | ||
| Prepaid Expense And Other Assets Current | $895.0K | $2.2M | $4.9M | $4.9M | $2.3M | $2.1M | ||
| Liabilities Current | $21.9M | $14.5M | $28.3M | $23.1M | $19.8M | $32.3M | ||
| Liabilities And Stockholders Equity | $13.8M | $52.4M | $119.7M | $225.7M | $254.4M | $244.9M | ||
| Liabilities | $50.0M | $38.2M | $49.0M | $45.4M | $43.6M | $35.0M | ||
| Assets Current | $8.0M | $51.2M | $116.4M | $220.4M | $247.3M | $240.7M | ||
| Assets | $13.8M | $52.4M | $119.7M | $225.7M | $254.4M | $244.9M | ||
| Accounts Payable And Accrued Liabilities Current | $16.4M | $13.7M | $26.7M | $21.6M | $18.4M | $12.1M | ||
| Other Assets Noncurrent | $163.0K | $0.00 | $154.0K | $154.0K | $154.0K | $154.0K | ||
| Common Stock Value | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | |||
| Operating Lease Right Of Use Asset | $5.5M | $512.0K | $1.5M | $2.4M | $3.3M | $0.00 | ||
| Operating Lease Liability Current | $1.4M | $836.0K | $1.6M | $1.5M | $1.4M | $0.00 | ||
| Liability To Licensor | $19.8M | $19.8M | $19.8M | $19.8M | $19.8M | $0.00 | ||
| Operating Lease Liability Noncurrent | $4.8M | $0.00 | $836.0K | $2.5M | $4.0M | $0.00 | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Property Plant And Equipment Additions | $0.00 | $1.0K | $1.0K | $17.0K | $172.0K | |||
| Gain Loss On Sale Of Property Plant Equipment | -$185.0K | $0.00 | -$2.0K | -$13.0K | -$4.0K | $0.00 | -$3.0K | |
| Tax Related To Net Settlement Of Equity Award Included In Accounts Payable And Accrued Expenses | $0.00 | $6.0K | $67.0K | $291.0K | ||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $690.0K | -$2.9M | $0.00 | ||||
| Gain Loss On Warrant Liability | $295.0K | $807.0K | $0.00 | |||||
| Tax Related To Net Settlement Of Equity Awards Included In Accounts Payable And Accrued Expenses | -$291.0K | $0.00 | $0.00 | |||||
| Warrant Liability | $3.5M | $3.8M | $0.00 | |||||
| Issuance Of Common Stock For Director Compensation Value | $107.0K | |||||||
| Equity Issuance Costs Included In Accounts Payable And Accrued Expenses | $0.00 | $445.0K | $0.00 | $0.00 | $1.9M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$31.2M | -$16.7M | $547.0K | $23.0M | $31.4M | $49.7M | $94.7M | $124.5M | $156.4M | $142.6M | $165.0M | $190.1M | $230.7M | $178.0M | $195.9M | -$74.5M | -$63.8M | -$57.6M | -$56.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $8.3M | $18.2M | $32.4M | $56.5M | $61.7M | $80.6M | $141.3M | $168.7M | $192.7M | $178.1M | $202.3M | $219.4M | $269.9M | $207.6M | $221.2M | ||||||
| Cash And Cash Equivalents At Carrying Value | $8.3M | $18.2M | $32.4M | $56.5M | $61.7M | $80.6M | $141.3M | $168.7M | $192.7M | $178.1M | $202.3M | $219.4M | $269.9M | $207.6M | $221.2M | $56.8M | $184.0K | $370.0K | |||
| Taxes Related To Net Share Settlement Of Equity Awards | -$6.0K | -$5.0K | -$29.0K | -$10.0K | -$14.0K | -$22.0K | -$46.0K | -$61.0K | -$66.0K | -$127.0K | -$56.0K | -$146.0K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$16.7M | -$30.8M | -$22.8M | -$25.6M | -$17.4M | -$3.3M | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$535.9M | -$520.1M | -$501.4M | -$471.2M | -$460.6M | -$439.5M | -$389.3M | -$356.0M | -$320.3M | -$265.3M | -$239.5M | -$210.6M | -$162.9M | -$140.0M | -$109.6M | ||||||
| Property Plant And Equipment Net | $324.0K | $380.0K | $495.0K | $906.0K | $1.1M | $1.4M | $2.0M | $2.2M | $2.5M | $3.0M | $3.3M | $3.4M | $3.9M | $4.2M | $4.4M | ||||||
| Prepaid Expense And Other Assets Current | $1.4M | $2.4M | $5.2M | $4.1M | $4.8M | $5.8M | $6.2M | $6.6M | $7.0M | $5.2M | $4.9M | $4.6M | $3.6M | $4.7M | $3.4M | ||||||
| Liabilities Current | $18.0M | $16.6M | $16.0M | $19.5M | $17.5M | $19.3M | $35.6M | $33.7M | $26.3M | $23.8M | $25.5M | $17.2M | $45.2M | $36.2M | $30.5M | ||||||
| Liabilities And Stockholders Equity | $15.9M | $27.1M | $38.3M | $62.2M | $68.6M | $89.2M | $151.4M | $179.6M | $204.6M | $189.1M | $213.5M | $230.7M | $277.6M | $216.7M | $229.1M | ||||||
| Liabilities | $47.1M | $43.9M | $37.7M | $39.3M | $37.3M | $39.5M | $56.7M | $55.1M | $48.1M | $46.5M | $48.5M | $40.6M | $46.9M | $38.7M | $33.2M | ||||||
| Assets Current | $9.7M | $20.6M | $37.5M | $60.6M | $66.5M | $86.4M | $147.5M | $175.3M | $199.7M | $183.3M | $207.2M | $224.0M | $273.5M | $212.3M | $224.6M | ||||||
| Assets | $15.9M | $27.1M | $38.3M | $62.2M | $68.6M | $89.2M | $151.4M | $179.6M | $204.6M | $189.1M | $213.5M | $230.7M | $277.6M | $216.7M | $229.1M | ||||||
| Accounts Payable And Accrued Liabilities Current | $16.8M | $15.8M | $15.5M | $18.2M | $15.8M | $17.8M | $34.0M | $32.1M | $24.7M | $22.3M | $24.0M | $15.8M | $24.9M | $15.9M | $10.3M | ||||||
| Other Assets Noncurrent | $163.0K | $163.0K | $0.00 | $0.00 | $154.0K | $154.0K | $154.0K | $154.0K | $154.0K | $155.0K | $154.0K | $154.0K | $154.0K | $154.0K | |||||||
| Common Stock Value | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | |||||
| Operating Lease Right Of Use Asset | $5.8M | $258.0K | $763.0K | $1.0M | $1.3M | $1.7M | $2.0M | $2.2M | $2.6M | $2.9M | $3.1M | ||||||||||
| Operating Lease Liability Current | $1.2M | $805.0K | $554.0K | $1.3M | $1.7M | $1.5M | $1.6M | $1.6M | $1.5M | $1.5M | $1.5M | $1.4M | |||||||||
| Liability To Licensor | $19.8M | $19.8M | $19.8M | $19.8M | $19.8M | $19.8M | $19.8M | $19.8M | $19.8M | $19.8M | $19.8M | $19.8M | |||||||||
| Operating Lease Liability Noncurrent | $5.0M | $5.2M | $0.00 | $0.00 | $415.0K | $1.3M | $1.7M | $2.1M | $2.8M | $3.2M | $3.6M | ||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Property Plant And Equipment Additions | $0.00 | $23.0K | $74.0K | $155.0K | |||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | |||||||||||||||||||||
| Tax Related To Net Settlement Of Equity Award Included In Accounts Payable And Accrued Expenses | $0.00 | $9.0K | $17.0K | ||||||||||||||||||
| Gains Losses On Extinguishment Of Debt | $690.0K | $0.00 | -$2.7M | -$174.0K | |||||||||||||||||
| Gain Loss On Warrant Liability | -$2.1M | -$297.0K | $1.9M | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Tax Related To Net Settlement Of Equity Awards Included In Accounts Payable And Accrued Expenses | $17.0K | $32.0K | $0.00 | ||||||||||||||||||
| Warrant Liability | $4.3M | $2.2M | $1.9M | ||||||||||||||||||
| Issuance Of Common Stock For Director Compensation Value | $27.0K | $54.0K | |||||||||||||||||||
| Equity Issuance Costs Included In Accounts Payable And Accrued Expenses |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $5.4M | $8.9M | $13.5M | $14.6M | $25.1M | $3.0M | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$48.2M | -$71.9M | -$104.0M | -$90.4M | -$62.2M | -$36.3M | -$9.6M |
| Net Cash Provided By Used In Financing Activities | $6.3M | $9.5M | $77.0K | $61.2M | $69.5M | $271.8M | $4.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.1M | -$2.9M | $11.0K | $2.6M | $237.0K | $1.3M | -$939.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.8M | -$13.5M | $5.3M | $3.4M | $8.0M | -$1.7M | $3.2M |
| Depreciation Depletion And Amortization | $373.0K | $925.0K | $1.2M | $1.2M | $1.3M | $1.0M | $860.0K |
| Payments To Acquire Machinery And Equipment | $0.00 | $98.0K | $268.0K | $924.0K | $590.0K | $1.5M | |
| Net Cash Provided By Used In Investing Activities | $0.00 | -$98.0K | -$265.0K | -$924.0K | -$590.0K | -$1.5M | |
| Increase Decrease In Operating Lease Liability | $344.0K | -$641.0K | -$593.0K | -$513.0K | -$331.0K | $0.00 | $0.00 |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 100.0K | 342.0K | 336.0K | 289.0K | 289.0K | 0.00 | 0.00 |
| Payments For Taxes Related To Net Settlement Of Equity Awards1 | $52.0K | $46.0K | $259.0K | $758.0K | $0.00 | ||
| Increase Decrease In Accrued Interest Receivable Net | $0.00 | -$3.0K | -$864.0K | -$1.3M | |||
| Proceeds From Issuance Of Common Stock | $0.00 | $9.2M | $0.00 | $61.7M | $71.0M | $0.00 | $0.00 |
| Payments For Repurchase Of Initial Public Offering | $0.00 | $1.9M | $0.00 | $0.00 | |||
| Proceeds From Sale Of Other Property Plant And Equipment | $0.00 | $3.0K | $0.00 | ||||
| Proceeds From Issuance Of Debt | $0.00 | $2.8M | $4.0M | ||||
| Proceeds From Issuance Initial Public Offering | $0.00 | $200.2M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $1.3M | $1.4M | $1.6M | $2.2M | $2.5M | $2.3M | $3.5M | $3.7M | $3.6M | $3.6M | $3.8M | $3.6M | $4.4M | $12.3M | $4.6M | $0.00 | $0.00 | $0.00 |
| Net Cash Provided By Used In Operating Activities | -$16.3M | -$30.8M | -$22.7M | -$25.1M | -$15.0M | -$3.8M | ||||||||||||
| Net Cash Provided By Used In Financing Activities | -$395.0K | -$13.0K | -$116.0K | -$405.0K | -$1.9M | $500.0K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.0M | $860.0K | $2.1M | $2.3M | $1.3M | $414.0K | ||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.1M | -$9.0M | $3.2M | -$2.4M | $117.0K | $2.5M | ||||||||||||
| Depreciation Depletion And Amortization | $183.0K | $240.0K | $293.0K | $313.0K | $309.0K | $216.0K | ||||||||||||
| Payments To Acquire Machinery And Equipment | $0.00 | $0.00 | $50.0K | $10.0K | $501.0K | $20.0K | ||||||||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | $0.00 | -$50.0K | -$10.0K | -$501.0K | -$20.0K | ||||||||||||
| Increase Decrease In Operating Lease Liability | -$28.0K | -$296.0K | -$146.0K | -$116.0K | -$56.0K | |||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | ||||||||||||||||||
| Payments For Taxes Related To Net Settlement Of Equity Awards1 | $29.0K | $13.0K | $116.0K | $405.0K | $0.00 | |||||||||||||
| Increase Decrease In Accrued Interest Receivable Net | $0.00 | -$1.0K | $379.0K | |||||||||||||||
| Proceeds From Issuance Of Common Stock | ||||||||||||||||||
| Payments For Repurchase Of Initial Public Offering | $0.00 | $1.9M | ||||||||||||||||
| Proceeds From Sale Of Other Property Plant And Equipment | ||||||||||||||||||
| Proceeds From Issuance Of Debt | $0.00 | $500.0K | ||||||||||||||||
| Proceeds From Issuance Initial Public Offering | -$1.9M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.01 | -$1.44 | -$2.58 | -$2.74 | -$2.76 | -$3.19 |
| Weighted Average Number Of Shares Outstanding Basic | 58.8M | 48.6M | 47.8M | 38.9M | 34.6M | |
| Weighted Average Number Of Diluted Shares Outstanding | 58.8M | 48.6M | 47.8M | 38.9M | 34.6M | |
| Earnings Per Share Basic | $-1.01 | $-1.44 | $-2.58 | $-2.74 | $-2.76 | |
| Common Stock Shares Issued | 63.5M | 58.1M | 48.1M | 46.3M | 35.8M | 32.2M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 63.5M | 58.1M | 48.1M | 46.3M | 35.8M | 32.2M |
| Common Stock Shares Authorized | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 34.6M | 8.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.27 | -$0.32 | -$0.26 | -$0.22 | -$0.44 | -$0.48 | -$0.70 | -$0.75 | -$0.58 | -$0.69 | -$0.77 | -$0.65 | -$0.68 | -$0.90 | -$0.56 | -$0.13 |
| Weighted Average Number Of Shares Outstanding Basic | 58.7M | 58.5M | 58.2M | 48.3M | 48.2M | 48.1M | 47.8M | 47.7M | 47.6M | 37.5M | 37.4M | 37.3M | 33.9M | 33.7M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 58.7M | 58.5M | 58.2M | 48.3M | 48.2M | 48.1M | 47.8M | 47.7M | 47.6M | 37.5M | 37.4M | 37.3M | 33.9M | 33.7M | ||
| Earnings Per Share Basic | $-0.27 | $-0.32 | $-0.26 | $-0.22 | $-0.44 | $-0.48 | $-0.70 | $-0.75 | $-0.58 | $-0.69 | $-0.77 | $-0.65 | $-0.68 | $-0.90 | ||
| Common Stock Shares Issued | 58.8M | 58.7M | 58.4M | 48.3M | 48.3M | 48.1M | 47.9M | 47.8M | 47.6M | 36.4M | 36.0M | 35.9M | 35.2M | 32.3M | 32.2M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 58.8M | 58.7M | 58.4M | 48.3M | 48.3M | 48.1M | 47.9M | 47.8M | 47.6M | 36.4M | 36.0M | 35.9M | 35.2M | 32.3M | 32.2M | |
| Common Stock Shares Authorized | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | 350.0M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 37.3M | 33.9M | 33.7M | 33.6M | 80.9M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Investment Income Interest | $843.0K | $3.4M | $6.3M | $1.6M | $350.0K | $100.0K | $128.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.4M | $8.9M | $13.5M | $14.6M | $25.1M | $3.0M | |
| Other Income Expense | -$1.0M | -$9.0K | -$87.0K | $10.0K | $1.0K | -$1.0K | -$22.0K |
| Additional Paid In Capital | $509.5M | $500.3M | $486.9M | $473.1M | $397.1M | $300.9M | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $100.0K | $342.0K | $336.0K | $289.0K | $289.0K | ||
| Fair Value Adjustment Of Warrants | -$295.0K | -$807.0K | $0.00 | $0.00 | $1.6M | $63.0K | |
| Related Party Transaction Amounts Of Transaction | $300.0K | $2.2M | |||||
| Stock Issued During Period Value New Issues | $61.7M | $71.0M | $198.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $133.0K | $233.0K | $400.0K | $692.0K | $900.0K | $1.2M | $1.7M | $1.5M | $1.5M | $370.0K | $146.0K | $85.0K | $76.0K | $80.0K | $98.0K | $31.0K | $1.0K | $5.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.3M | $1.4M | $1.6M | $2.2M | $2.5M | $2.3M | $3.5M | $3.7M | $3.6M | $3.6M | $3.8M | $3.6M | $4.4M | $12.3M | $4.6M | |||
| Other Income Expense | -$8.0K | $0.00 | $0.00 | -$39.0K | -$11.0K | -$10.0K | $30.0K | $3.0K | $7.0K | -$1.0K | ||||||||
| Additional Paid In Capital | $504.6M | $503.3M | $501.9M | $494.1M | $491.9M | $489.2M | $484.0M | $480.5M | $476.7M | $407.9M | $404.4M | $400.6M | $393.6M | $318.0M | $305.5M | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $47.0K | $244.0K | $14.0K | $173.0K | $19.0K | $190.0K | ||||||||||||
| Fair Value Adjustment Of Warrants | -$1.9M | $0.00 | $0.00 | $0.00 | $0.00 | $853.0K | $775.0K | $47.0K | ||||||||||
| Related Party Transaction Amounts Of Transaction | $0.00 | $1.8M | $0.00 | |||||||||||||||
| Stock Issued During Period Value New Issues | $71.1M |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.